Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling

Le Xu1, Yu Zhu, Jiejie Xu

  • 1Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

Cancer Science
|April 3, 2012
PubMed

Insights

Notch1 signaling activation promotes clear cell renal cell carcinoma (CCRCC) growth by influencing the PI3K/Akt pathway. This study establishes a key link between these pathways in CCRCC tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Clear cell renal cell carcinoma (CCRCC) exhibits aberrant activation of both Notch1 and PI3K/Akt signaling pathways.
  • These pathways are implicated in the complex mechanisms of CCRCC tumorigenesis.

Purpose of the Study:

  • To investigate the hypothesis that elevated Notch1 signaling activity promotes tumor growth in CCRCC by acting through the PI3K/Akt pathway.
  • To elucidate the functional relationship and collaboration between Notch1 and PI3K/Akt signaling in CCRCC progression.

Main Methods:

  • Manipulated Notch1 signaling activity in a CCRCC cell line and assessed downstream phosphorylated Akt (pAkt) levels.
  • Conducted cell proliferation, colony formation, and cell cycle analyses to evaluate tumor growth.
  • Utilized immunostaining of tissue microarrays to validate in vitro findings in vivo.

Main Results:

  • Notch1 signaling was found to be activated in CCRCC cell lines and tissue samples.
  • Notch1 activation significantly increased CCRCC cell proliferation, anchorage-independent growth, and accelerated G1/S cell cycle progression.
  • These Notch1-mediated effects were demonstrated to be at least partially dependent on the PI3K/Akt pathway.

Conclusions:

  • The study establishes a functional link between Notch1 and PI3K/Akt pathways in clear cell renal cell carcinoma.
  • Notch1 signaling plays a growth-promoting role in CCRCC, at least in part, through the PI3K/Akt pathway.
  • Correlations between Notch1, pAkt, and Ki-67 in patient samples support the in vitro findings and highlight therapeutic potential.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...